Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN<sup>TM</sup>): Early Clinical Results

Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN<sup>TM</sup>): Early Clinical Results

This is an early clinical analysis of the DEEPGENTM platform for cancer detection. Newly diagnosed cancer patients and individuals with no known malignancy were included in a prospective open-label case-controlled study (NCT03517332). Plasma cfDNA that was extracted from peripheral blood was sequenc...

Full description

Bibliographic Details
Main Authors: Frederic Ris, Minia Hellan, Jonathan Douissard, Jorge J. Nieva, Frederic Triponez, Yanghee Woo, David Geller, Nicolas C. Buchs, Leo Buehler, Stefan Moenig, Christophe E. Iselin, Wolfram Karenovics, Patrick Petignat, Giang Thanh Lam, Manuela Undurraga Malinervo, Rebecca Tuttle, James Ouellette, Debashish Bose, Nael Ismail, Christian Toso
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
liquid biopsy
DEEPGEN<sup>TM</sup>
cancer detection
early detection
cancer screening
cell-free DNA
Online Access:https://www.mdpi.com/2072-6694/13/16/4104

Internet

https://www.mdpi.com/2072-6694/13/16/4104

Similar Items